Published in Transpl Int on March 01, 2007
Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev (2010) 1.68
The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection. Eur J Nucl Med Mol Imaging (2016) 1.39
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol (2009) 1.08
Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. J Clin Microbiol (2008) 0.91
Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood (2007) 0.90
Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant (2011) 0.87
Post-transplant lymphoproliferative disease. Pediatr Nephrol (2007) 0.86
Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol (2008) 0.81
Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients. Virol J (2011) 0.79
Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease. Mediterr J Hematol Infect Dis (2009) 0.78
Hepatitis C and kidney disease: A narrative review. J Adv Res (2016) 0.77
Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience. Surg Today (2012) 0.77
Role of diffusion weighted imaging in diagnosis of post transplant lymphoproliferative disorders: Case reports and review of literature. Indian J Nephrol (2016) 0.75
Posttransplantation lymphoproliferative disorder involving liver after renal transplantation. Korean J Hepatol (2011) 0.75
Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management. World J Gastroenterol (2016) 0.75
(18)F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation. Nucl Med Mol Imaging (2016) 0.75
Metastatic Neuroendocrine Tumour in a Renal Transplant Recipient: Dual-Tracer PET-CT with (18)F-FDG and (68)Ga-DOTANOC in This Rare Setting. Nucl Med Mol Imaging (2014) 0.75
Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75
Pulmonary nodules and masses in lung transplant recipients: clinical and CT findings. Eur Radiol (2014) 0.75
Double-hit B-cell lymphomas. Blood (2010) 3.19
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. N Engl J Med (2015) 1.70
Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation (2009) 1.69
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood (2007) 1.60
Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship. Transplantation (2006) 1.44
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol (2007) 1.39
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood (2006) 1.39
Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk Lymphoma (2002) 1.25
Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function. Clin J Am Soc Nephrol (2010) 1.21
Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol (2005) 1.18
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant (2016) 1.16
Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Transplantation (2008) 1.13
Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant (2004) 1.07
Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol (2009) 1.07
Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation (2010) 1.04
Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation (2004) 1.03
Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation (2007) 1.02
A randomized clinical trial of living donor nephrectomy: a plea for a differentiated appraisal of mini-open muscle splitting incision and hand-assisted laparoscopic donor nephrectomy. Transpl Int (2012) 0.97
Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant (2005) 0.94
Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant (2006) 0.92
Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci (2005) 0.91
Social participation and employment status after kidney transplantation: a systematic review. Qual Life Res (2006) 0.90
Male sexuality after cancer treatment--needs for information and support: testicular cancer compared to malignant lymphoma. Patient Educ Couns (2004) 0.90
Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Med Sci Monit (2010) 0.90
HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical. Transplantation (2005) 0.90
Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant (2008) 0.90
EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma. Blood (2008) 0.90
Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant (2011) 0.90
Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation (2002) 0.87
The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol (2013) 0.87
The use of non-heart-beating lung donors category III can increase the donor pool. Eur J Cardiothorac Surg (2011) 0.87
N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population. Transplantation (2009) 0.85
Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation. Transplantation (2008) 0.85
Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials. Clin Lymphoma Myeloma Leuk (2011) 0.84
Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. Transplantation (2008) 0.84
Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients. Transplantation (2009) 0.83
Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study. J Rheumatol (2011) 0.83
The additional detrimental effects of cold preservation on transplantation-associated injury in kidneys from living and brain-dead donor rats. Transplantation (2009) 0.83
Lung transplantation for cystic fibrosis. Proc Am Thorac Soc (2009) 0.83
Plasma hemopexin activity in pregnancy and preeclampsia. Hypertens Pregnancy (2007) 0.82
Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma. Haematologica (2011) 0.82
The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant (2013) 0.82
Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study. Ann Hematol (2004) 0.81
Cross-sectional assessment of daily physical activity in chronic obstructive pulmonary disease lung transplant patients. J Heart Lung Transplant (2009) 0.81
Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant (2005) 0.81
Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients. Transplantation (2010) 0.81
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients. Nephrol Dial Transplant (2006) 0.81
Determinants of insulin resistance in renal transplant recipients. Transplantation (2007) 0.81
Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood. J Heart Lung Transplant (2008) 0.81
The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma. Haematologica (2006) 0.80
Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant (2013) 0.80
Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients. Transplantation (2007) 0.80
Social participation after successful kidney transplantation. Disabil Rehabil (2007) 0.79
Clinical factors influencing participation in society after successful kidney transplantation. Transplantation (2006) 0.79
Validation of insulin resistance indexes in a stable renal transplant population. Diabetes Care (2005) 0.79
Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro. Hypertension (2009) 0.79
Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation. Thromb Haemost (2008) 0.79
Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction. Am J Kidney Dis (2004) 0.79
Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int (2008) 0.79
Smoking is a risk factor for graft failure and mortality after renal transplantation. Am J Nephrol (2011) 0.79
Post-transplant lymphoproliferative disorders: from treatment to early detection and prevention? Haematologica (2007) 0.79
Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32. Mod Pathol (2003) 0.78
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion (2014) 0.78
Impact of depression on long-term outcome after renal transplantation: a prospective cohort study. Transplantation (2012) 0.78
Infection of human endothelium in vitro by cytomegalovirus causes enhanced expression of purinergic receptors: a potential virus escape mechanism? Transplantation (2007) 0.78
Assessment of Cotinine Reveals a Dose-Dependent Effect of Smoking Exposure on Long-term Outcomes After Renal Transplantation. Transplantation (2015) 0.77
Kinetics of US28 gene expression during active human cytomegalovirus infection in lung-transplant recipients. J Infect Dis (2006) 0.77
Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients. Transplantation (2002) 0.77
Clinical relevance of immunohistochemical staining for ecto-AMPase and ecto-ATPase in chronic allograft nephropathy (CAN). Nephrol Dial Transplant (2003) 0.77
Factors determining social participation in the first year after kidney transplantation: a prospective study. Transplantation (2007) 0.76
Histochemical detection of ischemia-like alterations induced in kidney tissue in vitro--different sensitivity to oxidant stress of glomerular ENTPD1 versus E5NT. Nephron Physiol (2008) 0.76
Extradural thoracic spinal cord compression: unusual initial presentation of post-transplant lymphoproliferative disorder. J Heart Lung Transplant (2008) 0.76
Insulin resistance as putative cause of chronic renal transplant dysfunction. Am J Kidney Dis (2003) 0.76
Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol (2012) 0.75
Long-term health and work outcomes of renal transplantation and patterns of work status during the end-stage renal disease trajectory. J Occup Rehabil (2011) 0.75
HLA matching and posttransplant lymphoproliferative disease after lung transplantation. Transplantation (2005) 0.75
Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report. Blood Coagul Fibrinolysis (2007) 0.75
Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation. Transplantation (2009) 0.75
Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients. Med Sci Monit (2011) 0.75
Dietary intervention after renal transplantation. Transplantation (2003) 0.75
Correction: Tolerance of Organ Transplant Recipients to Physical Activity during a High-Altitude Expedition: Climbing Mount Kilimanjaro. PLoS One (2015) 0.75
A staged approach for a lung-liver transplant patient using ex vivo reconditioned lungs first followed by an urgent liver transplantation. Transpl Int (2014) 0.75
Bronchoalveolar lavage in a patient with recurrence of sarcoidosis after lung transplantation. J Heart Lung Transplant (2004) 0.75
[Autologous stem cell transplantation in haematological disorders,1980-2002]. Ned Tijdschr Geneeskd (2010) 0.75
Scrotal irradiation in primary testicular lymphoma: review of the literature and in silico planning comparative study. Int J Radiat Oncol Biol Phys (2012) 0.75
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report. Biol Blood Marrow Transplant (2013) 0.75
Incidence of impaired renal function after lung transplantation. J Heart Lung Transplant (2011) 0.75
[Benign histiocytosis: Rosai-Dorfman disease]. Ned Tijdschr Geneeskd (2011) 0.75
A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia. Br J Haematol (2007) 0.75
To haemodialysis and back: saving a kidney graft by treatment of an arteriovenous fistula. Nephrol Dial Transplant (2005) 0.75